We have infrastructure to perform Whole Genome Sequencing (WGS) of SARS Cov2, used for genome surveillance. Although being an excellent tool, application of WGS for public health programs can be expensive.
Using Next-Generation Sequencing (NGS), it is now possible to perform identification of Mycobacterium tuberculosis infection in an unprecedented speed. This is significant, considering the large population size of countries where the burden of Tuberculosis (TB) is high.
Cultureless NGS method, faster Drug Resistance profiling from sputum, BAL, CSF, ascitic fluid, biopsy or any clinical sample. The early detection of MDR/Pre-XDR/XDR-TB could guide clinicians in the appropriate adjustment of MDR-TB treatment regimen with effective drugs to prevent treatment failure.
NGS-based profiling of antimicrobial resistance markers in antibiotic resistant microbes.
Whole-genome sequencing of human genome (using NGS) and computation analysis to identify variants which can be useful in clinical decision-making (precision medicine), wellness and preventive genetics.
Metagenomic analysis for identification of bacteria and fungi in respiratory samples through NGS.
